With FDA meeting in 6 weeks...and slight delay on EMA start...
Would not be surprised if the EMA and FDA trials merge as part of one "pivotal" Phase IIB trial...with FDA arm being combination therapy.
Hence, there will be a partner to fund and possibly run the FDA arm.
Just can't see Nuket and George managing all this on their own.
A few more twists and turns to come
.
Ann: ATL1102 DMD Paediatric Investigation Plan submitted to EMA, page-5
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $121.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 300000 | 1 |
View Market Depth
| Last trade - 10.35am 16/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable